CITADEL ADVISORS LLC

Position in VTVT — vTv Therapeutics Inc.

CIK 1423053 MIAMI, FL

Position in VTVT

as of Jun 30, 2026 · filed Sep 2, 2026 Compact

Position Value

$222,360

+$202,776 QoQ

Shares Held

5,906

+874.6% QoQ

Ownership

0.149%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#26

of 45 holders

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. VTVT ranks #310 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd.	1,425,517	$406,229,578
2	BBIO	BridgeBio Pharma, Inc.	3,760,028	$280,046,885
3	INSM	INSMED Inc	2,556,973	$272,624,460
4	MDGL	Madrigal Pharmaceuticals, Inc.	507,233	$272,358,759
5	VRTX	Vertex Pharmaceuticals Inc / Ma	510,430	$253,545,893
6	JAZZ	Jazz Pharmaceuticals plc	1,006,676	$242,578,715
7	MANE	Veradermics, Inc	1,877,775	$230,853,658
8	ROIV	Roivant Sciences Ltd.	5,576,261	$197,343,876

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$222,360	5,906	-75.6%	Shares	Defined	2026-09-02
2023-03-31	$19,584	24,238	-50.4%	Shares	Defined	2023-05-15
2022-12-31	$32,394	48,860	+48.0%	Shares	Defined	2023-02-14
2022-09-30	$32,021	33,012	-11.4%	Shares	Defined	2022-11-14
2022-06-30	$27,950	37,268	-60.4%	Shares	Defined	2022-08-15
2021-12-31	$93,649	94,120	-27.2%	Shares	Defined	2022-02-14
2021-09-30	$197,875	129,331	+1.2%	Shares	Defined	2021-11-15
2021-06-30	$291,484	127,844	-29.0%	Shares	Defined	2021-08-16
2021-03-31	$507,876	180,098	+1140.5%	Shares	Defined	2021-05-21
2020-09-30	$25,696	14,518	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.